OxTalks is Changing
On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Marburg Vaccine Trial
Summary:
Marburg virus, a filovirus related to Ebolavirus, has caused multiple outbreaks across sub-Saharan Africa since its discovery in 1967, most recently in Rwanda in 2024 and Tanzania in 2025. With a case fatality rate of up to 88% and no currently licensed vaccines or therapeutics, development of a safe and effective vaccine remains an urgent global priority.
The Oxford Vaccine Group has developed a novel vaccine against Marburg virus disease, ChAdOx1 Marburg. Using the same viral vector technology as the Oxford/AstraZeneca COVID-19 vaccine, ChAdOx1 Marburg has shown promising preclinical results and is now being evaluated in a first-in-human clinical trial in Oxford. We will discuss pre-clinical data generated so far, the ongoing clinical trial and likely steps to licensure.
Bios:
Jennifer Cane is a Senior Postdoctoral Scientist in the Outbreak Pathogens group headed by Professor Teresa Lambe, within the Oxford Vaccine Group. Jennifer is an immunologist with interests in vaccine development against emerging pathogens.
Peter Skidmore is a clinician and DPhil candidate working on Marburg virus vaccine development under Prof Lambe within the Oxford Vaccine Group, and the lead clinical fellow on the first-in-human clinical trial of ChAdOx1 Marburg.
Date:
3 February 2025, 13:00
Venue:
Big Data Institute, Old Road Campus OX3 7LF
Venue Details:
Seminar rooms
Speakers:
Dr Jennifer Cane (University of Oxford),
Peter Skidmore (University of Oxford)
Organising department:
Nuffield Department of Population Health
Organiser:
Professor Angela Brueggemann (Oxford Population Health)
Organiser contact email address:
alison.lewis@ndph.ox.ac.uk
Host:
Professor Angela Brueggemann (Oxford Population Health)
Part of:
IDEU Infectious Disease Seminar Series
Booking required?:
Not required
Audience:
Members of the University only
Editors:
Alison Lewis,
Angela Brueggemann
